Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading
暂无分享,去创建一个
G. Blobe | A. Zijlstra | Xiaojiang Xu | Xia Gao | T. Ketova | Hongyu Tian | Duriel Hardy
[1] E. Boscolo,et al. Endoglin regulates mural cell adhesion in the circulatory system , 2015, Cellular and Molecular Life Sciences.
[2] K. Walter,et al. Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer , 2015, British Journal of Cancer.
[3] M. Goumans,et al. Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors , 2015, Clinical Cancer Research.
[4] W. Young,et al. Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia , 2014, PloS one.
[5] R. Kerbel,et al. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment , 2013, Angiogenesis.
[6] C. Cabañas,et al. Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. , 2013, Blood.
[7] L. Liaw,et al. BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. , 2012, Blood.
[8] N. Katsanis,et al. Endoglin mediates fibronectin/α5β1 integrin and TGF‐β pathway crosstalk in endothelial cells , 2012, The EMBO journal.
[9] T. Seki,et al. Age-Dependent Lethality in Novel Transgenic Mouse Models of Central Nervous System Arteriovenous Malformations , 2012, Stroke.
[10] R. Pyeritz,et al. Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis , 2011, Genetics in Medicine.
[11] E Wiercinska,et al. Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma , 2011, Oncogene.
[12] J. Santibañez,et al. The Role of the TGF-β Coreceptor Endoglin in Cancer , 2010, TheScientificWorldJournal.
[13] Rachael J. Oakenfull,et al. Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.
[14] T. Nishida,et al. Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. , 2009, Investigative Ophthalmology and Visual Science.
[15] J. López-Novoa,et al. The emerging role of TGF-beta superfamily coreceptors in cancer. , 2009, Biochimica et biophysica acta.
[16] A. Terzić,et al. Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[17] Andrés J. García,et al. Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. , 2009, Molecular biology of the cell.
[18] Sophie Astrof,et al. Fibronectins in vascular morphogenesis , 2009, Angiogenesis.
[19] A. Magis,et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. , 2008, Journal of medicinal chemistry.
[20] G. Blobe,et al. Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC* , 2008, Journal of Biological Chemistry.
[21] L. David,et al. Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.
[22] S. Landolfo,et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. , 2008, Gynecologic oncology.
[23] D. Hammer,et al. Integrin-mediated signalling through the MAP-kinase pathway. , 2008, IET systems biology.
[24] A. Fertala,et al. Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. , 2007, Current pharmaceutical design.
[25] B. Conley,et al. Endoglin is required for myogenic differentiation potential of neural crest stem cells. , 2007, Developmental biology.
[26] G. Blobe,et al. The Interaction of Endoglin with β-Arrestin2 Regulates Transforming Growth Factor-β-mediated ERK Activation and Migration in Endothelial Cells* , 2007, Journal of Biological Chemistry.
[27] M. V. Dinther,et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.
[28] L. David,et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.
[29] G. Blobe,et al. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. , 2007, The Journal of biological chemistry.
[30] L. David,et al. Identification of BMP 9 and BMP 10 as functional activators of the orphan activin receptor-like kinase 1 ( ALK 1 ) in endothelial cells , 2007 .
[31] N. M. Khazenzon,et al. Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. , 2006, Frontiers in bioscience : a journal and virtual library.
[32] J. Wrana,et al. Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor β1 with Higher Affinity Receptors and an Activated Alk1 Pathway* , 2005, Journal of Biological Chemistry.
[33] E. Morrisey,et al. High‐efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α‐Cre transgenic mice , 2005, Genesis.
[34] M. Goumans,et al. Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.
[35] D. Banville,et al. Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins* , 2004, Journal of Biological Chemistry.
[36] Joshua D. Smith,et al. Endoglin Controls Cell Migration and Composition of Focal Adhesions , 2004, Journal of Biological Chemistry.
[37] M. Maio,et al. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels , 2003, Oncogene.
[38] D. Parums,et al. Inducible expression of human endoglin during inflammation and wound healing in vivo , 2002, Inflammation Research.
[39] T. Sanchez-Elsner,et al. Extracellular and Cytoplasmic Domains of Endoglin Interact with the Transforming Growth Factor-β Receptors I and II* , 2002, The Journal of Biological Chemistry.
[40] David A. Cheresh,et al. Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.
[41] Xin-Yuan Fu,et al. Focal Adhesion Kinase Activates Stat1 in Integrin-mediated Cell Migration and Adhesion* , 2001, The Journal of Biological Chemistry.
[42] P. Carmeliet,et al. Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.
[43] B. Conley,et al. Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. , 2000, Atherosclerosis.
[44] M. Labinaz,et al. Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-&bgr;–Induced Inhibition of Smooth Muscle Cell Migration , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[45] Dean Y. Li,et al. Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.
[46] M. Basson,et al. Human caco-2 motility redistributes FAK and paxillin and activates p38 MAPK in a matrix-dependent manner. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[47] C. Damsky,et al. FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.
[48] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Dumont,et al. A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.
[50] T. Rando,et al. Integrin-mediated Muscle Cell Spreading , 1999, The Journal of Biological Chemistry.
[51] D. Schlaepfer,et al. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.
[52] B. Brooke,et al. Defective angiogenesis in mice lacking endoglin. , 1999, Science.
[53] J. Wrana,et al. Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.
[54] L. Attisano,et al. Role of Endoglin in Cellular Responses to Transforming Growth Factor-β , 1998, The Journal of Biological Chemistry.
[55] P. Adam,et al. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. , 1998, Biochemical and biophysical research communications.
[56] D. W. Johnson,et al. Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.
[57] P. Lastres,et al. Endoglin modulates cellular responses to TGF-beta 1 , 1996, The Journal of cell biology.
[58] J. Parsons,et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.
[59] D. W. Johnson,et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.
[60] J. Massagué,et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.
[61] B. Jacobson,et al. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. , 1990, The Journal of investigative dermatology.